Even before Pfizer's historic announcement that its COVID-19 vaccine trial was showing 90% efficacy, the S&P 500 was on track to break out above important resistance.
In addition to my concerns about the Fed's money printing machine and the election just over four months away, keep an eye on these "vaccine stocks" that are getting fueled by rampant speculation.
Another Crypto Winter Wipes Out Billions in Market Value